ClinicalTrials.gg
Not yet recruitingNCT05968547D&GUpdated Aug 1, 2023

Evaluation of Patients' Requirements for Improved Advice and Guidance on Vision Standards for Driving in Glaucoma

An observational study in Glaucoma, sponsored by Manchester University NHS Foundation Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2023-08-01.

Sponsored by Manchester University NHS Foundation Trust · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2023, 3 years ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 110 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Glaucoma with a site in United Kingdom — 4 open to participants now, 5 under way, none of them phase 3. Glaucoma · United Kingdom.

Planned enrollment
9th of 20
100 · median 100
Started
2023
with 1 other
Observational
20 of 48
2 open now
Registered
45th of 48
by date
Lead sponsor
2 of 48
Manchester University NHS Foundation Trust

Among the 48 studies in Glaucoma with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 20 observational ones that give a count, is one of 2 that started in 2023, is one of 20 observational ones, and was the 45th registered.

Glaucoma

1,421 studies on the registry are indexed under Glaucoma; 221 are open to participants now.

Browse Glaucoma studies →

Open to participants now

4 of the 48 studies in Glaucoma with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 154 Glaucoma studies recruiting now, 112 (73%) set no upper age limit and 9 (6%) stop at 75 or younger; 13 take children under 18; 44 take healthy volunteers.

This study: 18 Years to 110 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Glaucoma with a site in United Kingdom, or all of them as a file.
02

Study summary

Glaucoma can affect both central and peripheral vision. Clinicians need to discuss with patients the vision related driving standards and any specific limitations their patients may have relating to their ability to drive with glaucoma. According to the recent guidelines by the General Optical Council (GOC), clinicians are advised to make sure that the Driving and Vehicle Licensing Agency (DVLA) is informed about patients who do not meet the driving vision standards. There are several limitations in making a professional judgement about a patient's suitability to drive and in providing appropriate advice to patients. The main concern is discussing this sensitive issue with the patient based upon available clinical evidence e.g. vision or visual field and directing them to inform the DVLA of their condition or potentially advising them to stop driving. The purpose of this research is to investigate the two main issues 1. To explore patients' understanding of standards of vision for driving. 2. Comparing the standards of vision for driving estimated in the clinic with number plate vision. We propose to do a mixed methods analysis using a patient survey and quantitative investigation of driving vision standards.

Read the detailed description

The two main objectives that we propose to study in this project are

  1. Descriptive understanding of patients' perception of their driving needs and their understanding of driving standards. This will be studied with the help of a survey questionnaire to learn about patients' driving needs, sight history, understanding of DVLA vision standards and the driving advice given to them. Understanding glaucoma patients' general perceptions about standards of vision for driving and their driving needs will help us to improve communication with the patients and to give the best possible advice about standards of vision for driving.
  2. Quantitative comparison of standards of vision for driving as required by DVLA and clinical vision assessment in glaucoma patients. The limitations to meet the vision standard for driving will be assessed in glaucoma patients in the clinic and outside the clinic as required by DVLA standards of vision for driving. In the clinic, vision will be assessed by checking if the patient can binocularly read the 6/12 line on the vision chart and electronic number plate test used in the clinic. The results will be compared with a self-assessed number plate vision - a standard requirement to meet DVLA's standard of vision for driving. Understanding the clinical estimation of binocular vision, patients' ability to read the number plate in clinic and to self-assess their number plate vision will help the clinician to know patients' abilities and give evidence-based advice to the glaucoma patient about meeting the DVLA standards of vision.
03

Conditions studied

  • Glaucoma

Browse trials for

Keywords

  • Driving Standards
  • DVLA
  • Glaucoma
04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients attending glaucoma clinics.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients attending the glaucoma clinic will be eligible for the survey.
  • Both drivers and non-drivers will be included in the study.

Inclusion Criteria for Quantitative vision estimation:

  • Glaucoma patients with habitual vision of 6/19 or better at least in one eye (whether driving or not driving).

Exclusion criteria

Exclusion criteria for Patient survey:

  • All the patients attending glaucoma clinic, willing to participate in the study, will be eligible to participate in the survey and will not be excluded from the study.

Exclusion Criteria for Quantitative vision estimation:

  • Patients with a binocular habitual visual acuity of less than 6/19 will not be able to eligible to participate in qualitative vision assessment.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Glaucoma patients questionnaire

    Questionnaire to understand patients driving needs and understanding of driving vision standards

  • Visual acuity standards

    DVLA vision standard estimated in the clinic is compared with standandard car number plate outside the clinic. We estimate the vision in the clinic using standard visual acuity chart and electronic number plate vision and compare with number plate vision estimated outside the clinic by the patient. Instruction to estimate number plate vision will be provided to the patient.

    Other: Driving assessment in glaucoma patient

Interventions

  • OtherDriving assessment in glaucoma patient

    One group of patient will be given questionnaire while the other group will respond to a questionnaire while the other group will have vision assessment. Patients could participate in both groups.

    Also known as: 1. questionnaire to patient. 2.Assessment of vision using visual acuity chart and number plate vision

06

What researchers measure

Primary outcomes

  1. Ability to read 6/12 or above in vision chart with both eyes.

    Binocular Vision assessment in Logmar testing

    Time frame: 6 months

  2. Vision Chart score in each eye

    Unilateral Vision testing Logmar testing

    Time frame: 6 months

  3. Ability to read the number plate in the clinic displayed in the VDU

    Ability to read the number plate in the clinic displayed in the VDU comparative visual display unit

    Time frame: 6 months

  4. Ability to read the car number plate outside the clinic

    Ability to read the car number plate outside the clinic as per patients self assessment

    Time frame: 6 months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2023; primary completion for Oct 2023, 2 months later.

Of 111 non-industry observational studies under Glaucoma, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 208. This study's planned 2 months is below that.

Counting every sponsor, half of 135 studies reached it within 31 months; a quarter within 11 and three quarters within 208.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2023
First posted
Aug 1, 2023
StartEst.
Aug 25, 2023
Primary completionEst.
Oct 25, 2023
CompletionEst.
Dec 25, 2023
Last update
Aug 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05968547
Responsible party
Sponsor
First posted
Aug 1, 2023
Start date
Aug 25, 2023 (estimated)
Primary completion
Oct 25, 2023 (estimated)
Completion
Dec 25, 2023 (estimated)
Last update
Aug 1, 2023

Study contacts

Subash Sukumar
Contact
subash.sukumar@mft.nhs.uk
0161-276-6583
Subash Sukumar
Contact
subash.sukumar@mft.nhs.uk
01612766583
Subash Sukumar
principal investigator · Manchester Royal Eye Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion